Evidence map›Paper›PMID 32673144›Full record

ArticleThe neuroradiology journal2020

A novel treatment of a patient with a giant ruptured middle cerebral artery aneurysm by acute coiling followed by scheduled Pipeline flex placement.

Shikai Liang, Ren Yuan, Xianli Lv

Open access · greenAbstract readCase Reports
In one paragraph

Article in The neuroradiology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. The off-label uses of pipeline embolization device for complex cerebral aneurysms: Mid-term follow-up in a single center.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shikai LiangNeurosurgery Department, Beijing Tsinghua Chang gung Hospital, School of Clinical Medicine, Tsinghua University, PR China.
Ren YuanNeurosurgery Department, Beijing Tsinghua Chang gung Hospital, School of Clinical Medicine, Tsinghua University, PR China.
Xianli LvNeurosurgery Department, Beijing Tsinghua Chang gung Hospital, School of Clinical Medicine, Tsinghua University, PR China.ORCID https://orcid.org/0000-0001-8270-8464
Beijing Tsinghua Chang Gung Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveFlow diversion in the acute phase of aneurysm rupture or giant aneurysm is limited by the need for dual antiplatelet therapy and the risk of delayed aneurysm rupture. Here, the authors report a scheduled flow-diversion concept for the endovascular treatment of a giant intra-dural aneurysm.

methodsA 54-year-old female patient with a ruptured giant middle cerebral artery aneurysm underwent coiling in the acute phase following 1-month scheduled Pipeline flex placement.

resultsThe acutely ruptured giant middle cerebral artery aneurysm was treated by flow diversion scheduled at 1 month after conventional coiling. The patient tolerated this treatment strategy well without any neurological deficits after the procedure and during the 3-month follow-up. The aneurysm showed nearly complete obliteration on 3-month follow-up angiogram, and a 6- to 12-month follow-up was scheduled.

conclusionsThis strategy may be considered as an option in patients presenting with ruptured or unruptured giant intra-dural aneurysms.

Indexed as

Aneurysm, RupturedEmbolization, TherapeuticFemaleHumansIntracranial AneurysmMiddle AgedMiddle Cerebral ArteryStentscoilflow diversiongiant aneurysmRupturescheduled

Identifiers

PMID32673144
PMCPMC7788672
OpenAlexW3043761830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.